Provide a detailed overview of congenital heart defects, describing their signs and symptoms, diagnostic criteria, and current medical and surgical management.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Congenital Heart Defects: Comprehensive Overview

Classification and Epidemiology

Congenital heart disease (CHD) occurs in approximately 0.4% to 1% of live births, with over 85% of affected infants now surviving to adulthood due to improved surgical and medical management. 1

CHD is fundamentally divided into three complexity categories based on anatomic and physiological severity 1:

Simple CHD (Class I)

  • Isolated small atrial septal defect (ASD) 1
  • Isolated small ventricular septal defect (VSD) 1
  • Mild isolated pulmonic stenosis 1
  • Previously repaired secundum ASD or VSD without residual shunt 1

Moderate Complexity CHD (Class II)

  • Atrioventricular septal defects (AVSD) 1
  • Coarctation of the aorta 1
  • Patent ductus arteriosus (moderate to large) 1
  • Ebstein anomaly 1
  • Repaired tetralogy of Fallot 1
  • Congenital aortic or mitral valve disease 1
  • Pulmonary valve stenosis or regurgitation (moderate or greater) 1
  • Anomalous coronary arteries 1

Great Complexity CHD (Class III)

  • All cyanotic congenital heart defects (unrepaired or palliated) 1
  • Single ventricle physiology (including hypoplastic left heart) 1
  • Fontan procedure 1
  • Transposition of the great arteries (d-TGA or l-TGA) 1
  • Truncus arteriosus 1
  • Pulmonary atresia 1
  • Double-outlet ventricle 1

Signs and Symptoms by Defect Type

Acyanotic Lesions

The primary clinical concern in acyanotic lesions is congestive heart failure rather than hypoxia. 2

Key presenting features include: 2

  • Feeding difficulties with concurrent tachypnea 2
  • Sweating during feeds 2
  • Subcostal retractions 2
  • Severe growth impairment/failure to thrive 2

Cyanotic Lesions

In cyanotic lesions, hypoxia is the predominant problem rather than congestive heart failure. 2

Clinical manifestations include: 3, 2

  • Central cyanosis (visible in mucous membranes) 3
  • Hypoxemic episodes ("tet spells" in tetralogy of Fallot) 3
  • Clubbing of digits (in chronic cases) 3
  • Exercise intolerance 3

Physiological Staging

The 2018 AHA/ACC guidelines classify physiological severity into four stages (A-D) regardless of anatomic complexity: 1

  • Stage A: NYHA Class I, no hemodynamic sequelae, normal exercise capacity 1
  • Stage B: NYHA Class II, mild hemodynamic sequelae, abnormal exercise testing 1
  • Stage C: NYHA Class III, significant valvular disease or ventricular dysfunction, hemodynamically significant shunt, controlled arrhythmias 1
  • Stage D: NYHA Class IV, severe complications including Eisenmenger syndrome, refractory arrhythmias, severe pulmonary hypertension, refractory end-organ dysfunction 1

Diagnostic Approach

Initial Evaluation

Chest radiography (posterior-anterior and lateral) is the first-line imaging test for suspected CHD, providing rapid assessment of cardiac contours, mediastinal anatomy, and pulmonary vascularity. 1

Advanced Imaging Modalities

All adults with suspected CHD require definitive imaging for diagnosis, and nearly all adults with known CHD require periodic imaging for monitoring. 1

Recommended imaging includes: 1

  • Echocardiography (transthoracic and transesophageal) - provides intracardiac anatomy and hemodynamics 1
  • Cardiac MRI (CMR) - superior for vascular anatomy and ventricular function 1
  • Cardiac CT angiography - excellent for great vessel anatomy 1
  • Cardiac catheterization with angiography - gold standard for hemodynamic assessment and intervention 1

Common pitfall: Approximately 10% of patients with common CHD survive undetected until adulthood, particularly those with small VSDs or ASDs. 1


Management and Treatment

General Principles

Patients with complex CHD have significantly better outcomes when managed in specialized, multidisciplinary ACHD (Adult Congenital Heart Disease) programs with board-certified ACHD cardiologists, congenital cardiac surgeons, and dedicated imaging services. 1

Acyanotic Defects

Ventricular Septal Defect (VSD)

Small, isolated VSDs without hemodynamic significance require observation only. 1

VSDs with associated abnormalities (such as aortic regurgitation from valve prolapse) or moderate-to-large shunts require surgical closure. 4

Critical surgical consideration: Complete heart block is a significant risk after perimembranous VSD repair because the His bundle passes along the defect rim. 4

Atrial Septal Defect (ASD)

Small ASDs without chamber enlargement require monitoring only. 1

Moderate to large ASDs with hemodynamically significant shunts require closure, either surgically or via transcatheter device. 1

Patent Ductus Arteriosus (PDA)

Small PDAs may be observed, but moderate to large PDAs require closure to prevent pulmonary vascular disease. 1

Transcatheter closure is preferred when anatomically feasible. 1

Coarctation of the Aorta

All significant coarctations require intervention to prevent hypertension, heart failure, and premature coronary disease. 1

Treatment options include surgical repair or balloon angioplasty with stenting. 1

Cyanotic Defects

Tetralogy of Fallot

Total surgical correction is the treatment of choice for tetralogy of Fallot. 3, 5

Some patients require initial palliation with a modified Blalock-Taussig shunt before complete repair, particularly those with severe pulmonary stenosis or hypoplastic pulmonary arteries. 3, 5

After repair, patients require lifelong monitoring for pulmonary regurgitation, right ventricular dysfunction, and arrhythmias. 1

Transposition of the Great Arteries (TGA)

For d-TGA with intact ventricular septum or simple VSD: arterial switch (Jatene) procedure is the definitive treatment. 3, 5

For d-TGA with VSD and pulmonary stenosis: Rastelli procedure (VSD closure with right ventricle to pulmonary artery conduit) is required. 3, 5

Neonates often require prostaglandin E1 infusion to maintain ductal patency and/or balloon atrial septostomy prior to definitive surgery. 3, 5

Tricuspid Atresia

Initial palliation is required at presentation: 3, 5

  • Modified Blalock-Taussig shunt for inadequate pulmonary blood flow 3, 5
  • Pulmonary artery banding for excessive pulmonary blood flow 3, 5

Staged Fontan procedure follows: 3, 5

  1. Bidirectional Glenn anastomosis (typically 4-6 months) 3, 5
  2. Fenestrated Fontan with extracardiac conduit (typically 2-4 years) 3, 5

Truncus Arteriosus

Surgical repair involves VSD closure combined with right ventricle to pulmonary artery conduit placement. 3, 5

Palliative pulmonary artery banding is no longer recommended. 5

Total Anomalous Pulmonary Venous Connection (TAPVC)

Non-obstructed TAPVC: elective surgical anastomosis of the common pulmonary vein to the left atrium. 3

Obstructed TAPVC: emergency surgical repair is required immediately at presentation to prevent death. 3

Hypoplastic Left Heart Syndrome and Other Single Ventricle Lesions

These require multistage surgical palliation (Norwood, Glenn, Fontan sequence) or cardiac transplantation. 3


Long-Term Complications and Monitoring

Adults with CHD develop acquired comorbidities including hypertension, atherosclerosis, coronary artery disease, pulmonary disease, and renal disease, which complicate management. 1

Common late complications requiring surveillance: 1

  • Arrhythmias (atrial and ventricular) 1
  • Ventricular dysfunction (systemic or pulmonary) 1
  • Valvular disease progression 1
  • Pulmonary hypertension and Eisenmenger syndrome 1
  • Heart failure 1
  • Thromboembolic events 1

Critical pitfall: Over half of adult CHD patients have undergone prior surgery, and 37% of all CHD hospital admissions are now adults, requiring specialized ACHD expertise. 1


Preventive Care

Follow-up should include routine well-child/adult care with modifications: 2

  • Influenza vaccination annually 2
  • Pneumococcal vaccination 2
  • More frequent monitoring if congestive heart failure is present 2
  • Addressing family psychosocial issues and clarifying expectations 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Associated Anomalies of Infracristal VSD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.